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INTRODUCTION 
 
Coronary artery disease is major cause of mortality and morbidity all over the 
world. There has been an alarming increase over the past two decades in coronary artery 
disease in India.In this condition there is reduced supply of blood and oxygen to a portion 
of myocardium and there is imbalance between myocardial supply and the demand. 
It includes:stable angina, unstable angina, myocardial infarction and sudden 
cardiac death.Approximately 50% of all the sudden cardiac death due to CAD occurs as 
the first clinical manifestation.The risk factors for the development of CAD includes 
smoking, high fat diet sedentary lifestyle, genetic factors, hypertension, diabetes mellitus, 
obesity. 
Coronary artery atherosclerosis is the principle cause of CAD where 
atherosclerotic changes develop within the walls of the coronary arteries. Atherosclerosis 
is a diffuse and degenerative disease of the arteries which results in plaques that contains 
necrotic cells,lipids and the cholesterol crystals. 
The major site of atherosclerosis is the epicardial coronary arteries. There is a 
predilection for atherosclerotic plaques to develop at sites where there is increased 
turbulence in coronary flow. There is limitation of the flow to meet the myocardial 
demand when the stenosis causes reduction in diameter of epicardial artery by 50%. 
The gold standard for the diagnosis of CAD is cardiac catheterisation with 
angiogram which is an invasive procedure and not used as first line.there are other tests to 
determine whether the patient with symptoms suggesting CAD have CAD such as ECG 
changes suggesting ischemia, treadmill exercise stress tests, myocardial perfusion 
imaging, multiple -gated acquisition scan, coronary artery calcium scans, cardiac 
magnetic resonance imaging, cardiac catheterisation and angiography. 
The thickening of the carotid intima-media is the initial stage for the development 
of atherosclerosis. this can be measured with the doppler ultrasound machine with high 
resolution transducer facility. 
Myocardial infarction (MI)or other acute coronary syndrome(ACS) may be the 
presenting symptom in 50% of the cases with cardiovascular disease. 
The impact of diabetes mellitus, hypertension, hyperlipidaemia, age, cigarette 
smoking, sex and hypertesion on IMT is well established already. However, the 
association between intima- media thickness (IMT) and atherosclerosis of the coronary 
arteries needs further investigations. 
Measurement of Carotid intima-media thickness is an economical and also a non 
invasive test which is sensitive and reliable for atherosclerosis. Measuring CIMT may be 
related to the severity of coronary artery disease and it may be instrumental in detection 
of patients with or without CAD and thus , CIMT measurement may trigger the 
preventive steps against atherosclerosis. 
High sensitivity C reactive protein (hsCRP) which is an inflammatory biomarker 
is also elevated in patients with CAD since there is also a role of inflammation in the 
pathogenesis of atherosclerosis. 
In this background , a study of CIMT in30 cases of CAD patients who have 
undergone angiography of various age groups and severity of vessel involvement was 
conducted in South Indian patients ,in southern districts of Tamil Nadu,who were 
attending Government Rajaji Hospital , Madurai . This study was undertaken in the 
department of medicine, Government Rajaji Hospital,Madurai. 
I hope this study will help in identifying patients with higher risk of CAD and also 
the severity of the disease and thus help in appropriate management of the disease . 
 
 
 
 
  
AIMS AND OBJECTIVES 
 
The aim of the current study is to investigate the 
a) The relation between intima-media thickness (IMT)in carotid arteries and the extent of 
coronary artery disease (CAD) 
b) Whether IMT is predictive of coronary atherosclerosis 
 
 
 
 
 
  
REVIEW OF LITERATURE 
 
 Blood vessels participate in homeostasiscontribute tothepathophysiology of 
diseases of every organ system.The understanding of vascular biology helps in 
understanding thenormal function of all organ systems and many diseases. Theblood 
vessels-capillariesconsist of a monolayer made of endothelialCells which are apposed to 
a basement membrane adjacent to occasionalsmooth-muscle-like cells known as 
“pericytes”. 
Arterieshave a trilaminar structure. The “intima”consists of a monolayer of 
endothelial cells which is continuous with those of the capillaries. 
The middle layeror the “tunicaMedia”,consists of layers of smooth-muscle cells. 
In the veins, the mediacan contain only a few layers of smooth-muscle cells and 
the outer layer “the adventitia”,consists of looser extracellular matrix which may have 
occasional fibroblasts,nerve terminals and mast cells. 
The Largerarteries have their own vasculature” the vasa vasorum”,which 
nourishesthe outer aspects oftunica media. Thesmaller arteries have a relatively thick 
tunica media in relation to the adventitia .The medium-sized muscular arteries  contain a 
“prominent tunicamedia”and the atherosclerosis commonly affects this type ofmuscular 
artery. 
 
Origin of vascular cells 
The intima in human arteries ,the intima often contains occasional residentsmooth-
muscle cells which lie beneath the monolayer of vascular endothelialcells. The origin of 
smooth-muscle cells differs for various typesof artery .during the developmental 
period,some of the upper-body arterial smooth-muscle cells are derived from the neural 
crest,and lower-body arteriesrecruitsmooth-muscle cells from the neighboring 
mesodermal structures. 
The derivatives of the proepicardial organ that which givesrise to the epicardial 
layer of the heartcontribute to the” vascularsmooth-muscle cells” of the coronary arteries. 
The endothelial cells derived from the Bone marrowmay aid in repair of the damaged or 
aging arteries. 
 
 
 
 
 
 
 
 
  
VASCULAR CELL BIOLOGY 
Endothelial Cell  
 The endothelial cell is the key cell of the vascular intima which has manifold 
functions in health and disease.It forms the interface between  blood compartment and the 
tissues.In a selective manner, the endothelium regulates the entry of molecules and cells 
into tissues .  
 The ability of endothelial cells to serve as a selectively permeable barrier fails in:  
 Atherosclerosis 
 Hypertension  
 Renal disease and  
 Other situations of"capillary leak."(pulomary oedema) 
 The endothelium plays a role in the local regulation of vascular calibre and the 
bloodflow.  
The endogenous substances produced by endothelialCells are 
 Prostacyclin 
 endothelium-derived hyperpolarizingFactor 
 nitric oxide (NO) and 
 hydrogen peroxide  
Under physiologic condition they provide a tonic vasodilatory stimuli in vivo. 
Impaired production or excess catabolism of NOimpairs this endothelium-dependent 
vasodilator function and maycontribute to excessive vasoconstriction in various 
pathologic situations. 
The endothelial vasoldilator function in humans can be assessed by measurement 
of flow-mediated dilatation. 
Under pathologic conditions the excessive production of reactive 
oxygenSpecies(e.g superoxide anion) by endothelial or smoothmuscle cells can promote 
the local oxidative stress and also inactivates the NO. 
 
ATHEROSOSCLEROSIS 
Pathogenesis: 
The current predictions have estimated that by the year 2020,atherosclerosis will 
become the leading cause of disease burden worldwide. Atherosclerosis affects various 
regions of circulation and atherosclerosis of coronary arteries cause myocardial infarction 
(MI) and angina pectoris. 
In coronary circulation, proximal LAD (left anterior descending artery) has 
predilection for developing atherosclerosis. 
Atherosclerosis occurs over a period of many years. 
 
  
MAJOR RISK FACTORS FOR ATHEROSCLEROSIS 
 High LDL cholesterol 
 cigarette smoking 
 Hypertension 
 Low H D L cholesterol' (< 1 .0 m mol/L [<40 mg/d L]) 
 Diabetes mellitus 
 Family history of premature CHD  
 Age (men ;>45 years; women >55 years) 
 Lifestyle risk factors 
 Obesity (BMI ;0,30 kg/m2) 
 Physical inactivity 
 Atherogenic diet 
 
Emerging risk factors 
 Lipoprotein (a) 
 Prothrombotic factors 
 Proinflammatory factors 
 Impaired fasting glucose 
 Subclinical atherosclerosis 
 
Growth of atherosclerotic plaques occur discontinuously and not in linear 
fashion.Fatty streaks are the early lesions which arise from lipoproteins within the 
regions of intima. Low density lipoproteins (LDL) which bear apolipoprotein B is 
causally related to atherosclerosis.The lipoproteins bind to the intima of the arteries and 
gets accumulated there increasing the residence time of lipid rich particles within arterial 
wall. 
Lipoproteins associate with proteoglycans of the extracellular matrix,which slow 
the egress of lipid rich particles from the intima. 
The lipoproteins undergo oxidative modifications giving rise to  
 Hydroxyperoxides, 
 Oxysterols, 
 Lysophospholipids and  
 Breakdown products of phospholipids and fatty acids. 
Leucocyte recruitment 
There is accumulation of the inflammatory cells in the astheroma like  
 macrophages  
 dendritic cells  
 mast cells and 
 T and B lymphocytes  
Adhesion molecules or receptors for leucocytes particate in recruitment of 
leucocytes to nascent atheroma. 
 The proinflammatory cytokine augment the expression of leucocyte “adhesion 
molecules”.Laminar shear forces suppress the leucocyte adhesion molecules.There is low 
shear stress and disturbed flow at the sites which has predilection for atherosclerotic 
lesions  
  Laminar shear stress stimulates the the production of superoxide dismutase 
by endothelial cells .The ordered and pulsatile laminar shear during normal blood flow 
augments Nitric oxide production which which in addition to vasodilatation acts as local 
anti-inflammatory autocoid.KLF2 , Kruppel -like factor which augments nitric oxide 
synthase is produced on exposure of endothlial cells to the laminar shear stress. 
 The leucocyte penetrates the endothelial layer after being captured by adhesion 
receptors on surface of endothelial cell. IL-1 and TNF( tumour necrosis factor) induce the 
expression of adhesion molecules. 
  
Foam cell formation 
 
  The mononuclear cells within the intima mature into macrophages and they 
become lipid-laden foam cells which requires uptake of lipoprotein particles by “receptor 
mediated - endocytosis” 
Atheroma evaluation and complications  
Fatty streaks precedes the development of atherosclerotic plaques but not all fatty 
streaks will form complex atheromata. The mononuclear macrophages by ingesting lipids 
may remove the lipoproteins from the developing lesion. 
There is also proliferation of macrophages in response to “hematopoietic growth 
factors” overexpressed in lesions. 
The reverse cholesterol transport may be another mechanism mediated by HDLs 
which provides an independent pathway for lipid removal from the atheroma. 
Some foam cells die of apoptosis and it results in formation of necrotic core which 
has a lipid- rich core. 
The impaired clearance of dead foam cells hastens lipid core formation. 
The bulk of the extracellular matrix of the lesion is synthesized by the smooth 
muscle cells. 
The cytokines elaborated by mononuclear phagocytes stimulate the formation of 
smooth-muscle cell proliferation. 
The platelet derived growth factor (PDGF) elaborated by macrophages, activated 
platelets and endothelial cells stimulate the migration of smooth -muscle cells which are 
normally resident in tunica media to intima. 
Transforming growth factor beta (TGF) stimulates the smooth- muscles for 
interstitial collagen production. 
Activated platelets release factors that promotes fibrotic response,including the 
PDGF and “transforming growth factor beta”. 
Microvessels  
Newly developing microvessels provide abundant surface area for “leucocyte 
trafficking” and also serve as a portal for the entry and exit of WBCs from the established 
atheroma .   
Plaque-evolution 
 
Smooth - muscle cells and macrophages die within the atherosclerotic plaque. 
A highly complex and and regulated balance between entry and egress of 
leucocytes and lipoproteins, cell proliferation and cell death , extracellular matrix 
production and remodelling, and calcification and and neovascularisation contribute to 
the lesion formation. 
Ischemic heart disease (IHD) 
It is condition in which there is “inadequate supply” of blood and oxygen to the 
myocardium. 
There is imbalance between the myocardial oxygen supply and the demand. 
Atherosclerotic disease of coronary artery is the most common cause of myocardial 
ischemia. 
Epidemiology 
 IHD cause more deaths, disability and economic costs than any other illness in the 
world. 
 The risk factors associated with Ischemic heart disease 
 A high fat diet 
  genetic factor 
 type 2 diabetes mellitus 
 sedentary lifestyle and 
  high fat diet  
Pathophysiology  
 There is an imbalance between the myocardial supply and the demand. 
The major determinants of the myocardial oxygen demand are: 
 Heart rate 
 Myocardial contractility 
 Myocardial wall tension(stress) 
An adequate supply of oxygen is requires adequate level of coronary blood flow 
and a satisfactory level of oxgen carrying capacity of the blood which is determined by : 
 the pulmonary function,  
 hemoglobin concentration and function,  
 inspired level of oxygen 
Blood through the coronary arteries flows in a phasic fashion and the majority occurs 
during diastole. 
Around 75% of the total coronary resistance to the flow occurs across three sets of 
arteries: 
 Large epicardial arteries ( resistance 1 = R1) 
 Prearteriolar vessels (R2) and  
 Arteriolar and intramyocardial capillary vessels (R3) 
The intramyocardial resistance vessels has a great capacity for dilatation (R2 and R3 
decreases). 
The coronary resistance vessels adapt to the physiologic alteration in the blood 
pressure to maintain the flow at levels which is appropriate to the myocardial needs ( 
autoregulation ). 
During Exercise or exitement,the coronary arteries reduce the lumen and thus 
atherosclerosis limits the the appropriate increase in perfusion when the demand is 
augmented. 
The myocardial perfusion is reduced in the basal state when there is 
severe reduction in the lumen diameter.Coronary blood flow also can be limited 
by arterial thrombi, spasm andrarely, coronary embolias well as by ostial narrowing due 
to aortitis. 
 
Coronary atherosclerois 
 The epicardial coronary arteries are the major site ofatheroscleroticdisease. 
 The major risk factors for atherosclerosis, disturb the normal functions of the 
vascularendothelium. 
These functions include  
 Local control of vascular tone 
 Maintenance of an antithrombotic surface 
 Control of inflammatorycell adhesion diapedesis. 
The loss of these defenses leadsto 
 Inappropriateconstriction  
 Luminal thrombus formation and 
 Abnormal interactions between blood cells, especially the platelets and 
monocytes and the activatedvascular Endothelium. 
 The formation of a plaque causes the narrowing of the epicardial coronary 
arteries,which issubject to erosion or rupture. 
 Upon exposure of the plaque contents to blood, twoprocesses are set in motion: 
(1) plateletsare activated and aggregated and  
(2) the coagulation cascade is activated, which leads to deposition of thefibrin 
strands.  
  The thrombus which is composedof fibrin and platelet aggregates, trap 
redblood cells and can reduce coronary blood flow, thus leading to the clinical 
manifestations of MI (myocardial ischemia). 
Coronary artery disease 
Coronary Artery Disease is the leading cause of deathworldwide. CAD is the 
pathologic process of atherosclerosis which affects the coronary arteries.  
It includes  
 angina pectoris 
 MI 
 silent myocardial ischemia 
 sudden cardiac death. 
 CLINICAL PRESENTATIONS 
Angina Pectoris 
Some patients have stable angina. In case of the Low-risk angina , it stable for a 
period of at least60days. 
That means, there is no significant change in the duration, precipitating 
causes,frequency or ease of relief.There is also no evidence of recentmyocardial damage. 
 
 
The features of Unstable angina (UA) or the high risk angina are 
a) New occurrence of angina 
b) Worsening of the chronic stable angina patternwith increased duration or 
frequency of the symptoms and  also new triggers and incomplete relief with the 
management of the symptom. 
c) Evidence of recent myocardial damage 
d) Symptoms of peripheral vascular disease 
Acute coronary syndrome  
The classical symptoms of ACS are : 
1. Chest pain and diaphoresis 
2. Upper abdominalpain 
3. Back pain, 
4. Throat/jaw pain, and  
5. Arm pain 
6. Gastrointestinal (gi) symptoms such as nausea, fullness,gas. 
7. Shortness of breath or dizzines. 
Acute myocardial infacrtionis diagnosed by a rise and fall inthe 
levelsofbiomarkers of myocardial necrosis,CK-MB and troponin, including at least one or 
moreof the following: 
 
1. myocardial ischemiac symptoms 
 2.Ischemic ECG changes ( the ST segment elevation or the depression) 
 3.Development of pathologic Q waves (ECG) 
4. new loss of viable myocardium on imaging or new RWMA 
 With reperfusion therapy for the acute MI, with either thrombolysis orangioplasty,the 
coronary perfusion is restored and the marker levels peak higher with more rapid washout 
declines, in comparison to the nonreperfused state.Cardiac biomarkers may be elevated 
even without acute coronary syndrome. 
The Levels ofCK-MB may be elevated in : 
 Skeletal trauma/myopathy 
 Cardiac trauma 
 Myocarditis 
 Severe hypothyroidism 
 Seizures 
 Cardioversion/defibrillation or 
 Renal failure. 
  The TroponinT levels are elevated in heart failure, Pulmonary 
embolism,coronary angioplasty,demand ischemia or myocardial infiltration. 
 
The differential of acute chest pain includes: 
1. Acute coronary syndrome 
2. Aorticdissection 
3. pericarditis 
4. pulmonary embolism 
5. GI problems such as GERD (gastroesophagealreflux disease) 
6. Peptic ulcer disease  
7. Musculoskeletal  
8. Biliary problems 
   
  
  The ECG changes are important for the diagnosis, localization, risk 
stratification, andmanagement of ACS. Acute infarctions are subdividedinto “ST-
elevation MI (STEMI)” and “non–ST-elevation MI (NSTEMI)”.In STEMI there isa 
transmural infarct in evolution, whereas NSTEMI is usually subendocardial. The “ 
PathologicQ” waves develop after STEMI, but they can also develop after NSTEMI. 
 During the acute symptoms,UA is mostly associated with ischemic T-wave 
inversion and also some ST-segmentdepression, but levels of biomarkers do not increase 
significantly. 
Silent myocardial infarction 
In Some patients there is no known event but they are found to have ECG 
evidence ofpreviousmyocardial damage. It is estimated that between 2% and 4% of 
healthyasymptomatic middle-aged men have significant Coronary Artery Disease and if 
there is presence of 2 or morerisk factors, the prevalence may approach 10%.Silent 
ischemia is morelikely to occur in older adults, persons with diabetics, older and those 
with prior MI or revascularizationprocedures. 
Sudden cardiac death 
In few patients, the first manifestation of CAD may bea sudden cardiac death. 
Thus recognizing those at risk for CAD will help in identifying such individuals and 
decreasethe incidence of such ominous presentation. 
The presentation of CAD in women may be confusing. The women are more likely to 
have less-typical symptomssuch as vomiting,shortness of breath, or jaw pain. Women are 
also likely to delay in seeking treatment. 
Risk factors 
a. Tobacco use—cessation of smoking should be the goal. 
b. Hyperlipidemia—identification and treatment improves outcome. 
c. Hypertension—lifestyle modifications with medicationsto achieve optimum control. 
d. Diabetes mellitus—it is a major risk factor and considered equivalent to 
coronaryheart disease . 
e. Obesity—it needs lifestyle management, with a small role for the medical andpossible 
surgical intervention. 
f. Sedentary lifestyle—the American College of Cardiology endorses  aerobic activity of  
minimum 30 to 60 minutes in most days of the week. 
  Some additional historical factors which may need to be considered such 
ashistory of hormone replacement therapy. The emerging risk factors thatare being 
identified and which may be useful to evaluate in some patients are:  
*evaluation of lipoprotein (a) 
*highly sensitive 
*C-reactive protein, 
*fibrinogen, and  
*homocysteine.  
  In presence of any of these riskfactors, there may be need to consider more 
aggressive therapy such as earlier additionof medication to the lifestyle management of 
hyperlipidemia. 
Clinical manifestations and pathology of coronary heart disease 
Clinical problem Pathology 
Stable angina Ischaemia due to fixed atheromatous stenosis of one or more coronary 
arteries 
Unstable angina 
 Ischaemia is caused by dynamicobstruction of a coronary artery due to the rupture 
of plaque or erosion withsuperimposed thrombosis 
Myocardialinfarction 
 Myocardial necrosis is caused by acuteocclusion of a coronary artery dueto the 
rupture plaqueor erosion withsuperimposed thrombosis 
Heart failure Myocardial dysfunction due to infarction Or the ischaemia 
Arrhythmia Altered conduction due to ischaemia or infarction 
Sudden death Ventricular arrhythmia, asystole or massive MI 
 
  
Factors influencing myocardial oxygen supply and demand 
Oxygen demand: cardiac work 
• BP 
• Heart rate 
• Myocardial contractility 
• Valve disease, e.g. aortic stenosis 
• Left ventricular hypertrophy 
Oxygen supply: coronary blood flow 
 Duration of diastole 
 Coronary 
 perfusion pressure (aortic diastolic minus the coronarysinus or the right atrial 
diastolic pressure) 
 Coronary vasomotor tone 
 Oxygenation 
 Haemoglobin 
 Oxygen saturation 
 
*Coronary blood flow occurs mainly in diastole. 
  
Activities precipitating angina 
Common 
• Cold exposure 
• Physical exertion 
• Heavy meals 
• Intense emotion 
Uncommon 
• Lying flat (decubitusangina) 
• Vivid dreams (nocturnalAngina) 
Risk stratification instable angina 
High risk 
a. Post-infarct angina  
b. Poor effort tolerance 
c. Ischaemia at low workload 
d. Left main or three vessel disease    
e. Poor LV function  
Low risk 
a. Predictable exertional angina 
b. Good effort tolerance  
c. Ischaemia only at high workload 
d. Single-vessel or two-vesselDisease 
e. Good LV function 
Diagnosis of CAD 
 There are some additional factors that has to be considered such ashistory of 
hormone replacement therapy.  
The emerging risk factors are  
1.evaluation of lipoprotein (a), 
2.highly sensitive 
3.C-reactive protein 
4.fibrinogen and 
5.homocysteine. 
 If any of these risk factors are present, more aggressive therapy such as earlier 
additionof medication to lifestyle management has to be considered for hyperlipidemia. 
Ecg  
It is the most of all the performed cardiac test. In the acute MI, the ECG may 
showST elevation which suggest ischemia. There may also be the evidenceof old MI with 
Q waves . there may be normal result in ecg if the heart is not under any stress, even if 
they have CAD. 
  
The 12-lead ECG examinations 
 Rhythm strip 
(lead II) 
To determine heart rate and rhythm 
 Cardiac axis Normal if QRS complexes +ve in leads I and II 
 P-wave shape 
 Tall P waves denote right atrial enlargement (P pulmonale) and notched P waves 
denote left atrial enlargement (P mitrale) 
 PR interval 
  Normal = 0.12–0.20 secs. Prolongation denotes impaired AV nodal 
conduction. A short PR interval occurs in Wolff–Parkinson–White syndrome (p. 565) 
 QRS duration If > 0.12 secs then ventricular conduction isabnormal (left or right 
bundle branch block) 
 QRS amplitude 
 Large QRS complexes occur in slim young patients and in patients with left 
ventricular hypertrophy 
 Q waves May signify previous myocardial infarction (MI) 
 ST segment 
  ST elevation may signify MI, pericarditis or left ventricular aneurysm; ST 
depression may signify myocardial ischaemia or infarction) 
 T waves 
  T-wave inversion has many causes, including myocardial ischaemia or 
infarction, and electrolyte disturbances 
 QT interval 
  Normal < 0.42 secs. QT prolongation may occur with congenital long QT 
syndrome, low K+, Mg2+ or Ca2+, and some drugs (see Box 18.35, p. 568) 
 ECGconventions 
  Depolarisation towards electrode: positive deflection Depolarisation away 
from electrode: negative deflection 
Sensitivity: 10 mm = 1 mV 
Paper speed: 25 mm per second 
Each large (5 mm) square = 0.2 s 
Each small (1 mm) square = 0.04 s 
Heart rate = 1500/RR interval (mm) (i.e. 300 ÷ number of large squares between beats) 
  
Continuous (ambulatory) ECG  
 The recordingsare obtained using a portable digital recorder. It usually provide 
limb lead ECG recordings only.It can record for between 1 and 7 days. 
  It is used in the investigation of patients with suspected arrhythmia( those 
withintermittent palpitation, dizziness or syncope). 
  It provides only a snapshot of thecardiac rhythm. 
  It is unlikely to detect any intermittentarrhythmia, so a longer period of 
recording is useful.The other uses are: 
 To assess rate control in patients with atrial fibrillation, 
 To detect transient myocardialischaemia using ST segment analysis 
 In patients withinfrequent symptoms,ECG recorders are issued for several weeks 
until asymptom episode  
  The device is placed on the chest to record the rhythm during the episode. 
Implantable ‘loop recorders’(small devices that resemble a leadless pacemaker)are 
implanted subcutaneously. Thelifespan of the device is1–3 years and they are used to 
investigate the patients with infrequent but potentially serious symptoms like syncope. 
Stress testing 
  The treadmill exercise stress test (TMET) is done to evaluatethe heart 
during exercise. Evidence of CAD may be present only in situations whenthe heart is 
being challenged.The patient may develop angina during the test, or changes in ECG or 
BP which suggest cardiac ischemia. Patients may also develop exertional hypotension or 
hypertension. It often indicates severe heart failure or a multivessel CAD. 
Other causes of hypotension include 
 Fixed cardiac output(in stenoticvalvular disease) 
 Hypertrophic cardiomyopathy,  
 Volume depletion 
 Drugs such as vasodilator. 
  In certain conditions the patient is physically unable to perform the exercise because 
of orthopedic ormedical issues. In such cases, the heart is chemically stimulated with a 
medication(dobutamine) 
  A stress echocardiogram is an option to assessthe potential of 
cardiacdysfunction during exercise testing. The echo may show reduced muscle or an 
absent wall activity if any area of myocardium is compromised during exercise. 
  
The Bruce Protocol for exercise tolerance 
Testing 
 speed  
 mph kmh Gradient %incline 
Stage 1 1.7 2.7 10 
Stage 2 2.5 4 12 
Stage 3 3.4 5.4 14 
Stage 4 4.2 6.7 16 
Stage 4 5 8 18 
Each stage lasts for three minutes 
 
Indications 
1. To evaluate stable angina 
2.  To assess prognosis following MI 
3.  To assess outcome after coronary revascularisation, e.g.coronary angioplasty 
4. To confirm the diagnosis of angina 
5. To diagnose and evaluate the treatment of exercise-inducedarrhythmias 
 
 High-risk findings 
 The fall in BP on exercise 
 Low threshold for ischaemia (i.e. within stage 1 or 2 of theBruce Protocol) 
 Low threshold for ischaemia (i.e. within stage 1 or 2 of theBruce Protocol) 
 Widespread, marked or prolonged ischaemic ECGChanges 
 Exercise-induced arrhythmia 
 Other diagnostic tests includes: 
Myocardial perfusion imaging 
Coronary Artery Calcium Scans 
Cardiac Magnetic Resonance Imaging 
Cardiac Catheterization and Angiography 
Angiogram is best way to determine if the coronary arteries are affected by CAD. 
Information can be obtained about coronary arteries and the valves. The LVEF wall 
motion abnormality can analyzed. The angiogram can be used inmultiple therapies such 
as stenting,angioplasty, or valvuloplasty. 
  
Other diagnostic tests includes: 
Myocardial perfusion imaging 
Coronary Artery Calcium Scans 
Cardiac Magnetic Resonance Imaging 
Cardiac Catheterization and Angiography 
 Angiogram is best way to determine if the coronary arteries are affected by CAD.  
Information can be obtained about coronary arteries and the valves . The LVEF wall 
motion abnormality can analyzed. The angiogram can be used inmultiple therapies such 
as stenting,angioplasty, or valvuloplasty. 
GENERAL MEDICAL MANAGEMENT OF ACUTE CORONARY SYNDROME 
The management of angina pectoris involves: 
A. a careful assessment of the likely extent and the severityof arterial disease 
B. The identification and control of risk factors such ashypertension,smokingand 
hyperlipidaemia 
C. The use of measures to control the symptoms 
D. The identification of high-risk patients for treatment 
E. To improve life expectancy 
  
Advice to patients with stable angina: 
1. Do not smoke 
2. Aim for ideal body weight 
3. Take regular exercise (exercise up to, but not beyond, thepoint of chest discomfort is 
beneficial and may promotecollateral vessels) 
4. Avoid severe unaccustomed exertion, vigorous exercisein very cold weather or after 
a heavy meal  
5. To take sublingual nitrate before undertaking exertion that mayinduce angina 
Aspirin 
It inhibits platelet aggregation.  
The recommended acute dose is 162 to 325 mg. 
If there is allergy to aspirin,clopidogrel should be used. 
b-Blockers 
 Metoprolol is given intravenously (IV) for short-term thanin oral form.  
The Contraindications to b-blocker in acute MI includes : 
1. Moderate to severe LV failure  
2. Cardiogenic shock Moderate to severe LV failure 
3. Second or third-degree AV block ( atrioventricular heart block) 
4. Hypotension with systolic BP less than 100 mm Hg 
5. Severe reactive airway disease Sinus bradycardia with HR less than 69 
6. Sinus bradycardia with HR less than 69 
Precautions should be taken in few conditions like: 
 Mild LV failure 
 Severe peripheral arterial occlusiveDisease, and 
 Severe chronic obstructive pulmonary disease 
Nitrates 
 Cause smooth muscle relaxation. 
  LV preload is reduced. 
 Coronary vasodilatation occurs.  
 Vasospasm isreversed 
Morphine 
  Morphine is given for pain control during an acute MI.It is given IVand titrated to 
decrease pain and as a result decreases patient anxiety by diminishingoxygen demand on 
the cardiac muscle. It also reduces preload by venodilatoryeffects. 
Oxygen 
  Supplemental oxygen is given during initial evaluation for acute 
coronarysyndrome. 
  
SPECIFIC MANAGEMENT OF ACUTE CORONARY 
 
SYNDROMES 
Acute MI Management: ST-Elevation MI: 
Streptokinaseand tissue plasminogen activators (t-PAs) are used to promote 
breakdown of clot. 
Percutaneous coronary intervention (PCI) is the most rapid way to achieve 
reperfusion; 
If there is no PCI immediately available, thrombolytic therapy should be initiated. 
The initial 60 minutes are referred to as “the golden hour”. 
  In the absence of contraindication, all the patients with STEMI should be 
thrombolysed with a t-PA agent and also those with the following features: 
 Onset of Symptom less than 12 hours before presentation 
 Ischemic ST-segment elevation of 0.1 mV or more in 2 or more contiguous limbleads 
or 2 mV or more in 2 or more contiguous precordial leads. 
 Symptoms compatible with acute MI and new left bundlebranch block 
  
MEDICAL MANAGEMENT OF CHRONIC CAD 
Aspirin 
 It is used in the treatment of acute cardiac event and also forsecondary prevention 
after MI, transient ischemic attack,stroke, or coronary revascularization.  
  Dailydoses of 75–162 mg for secondary prevention. 
  Aspirin along low molecular weight heparin is more effective than aspirin 
alone in reducing the combined endpoint of death,refractory angina,MI, and the urgent 
need for revascularisation. The pentasaccharide, fondaparinux (2.5 mg s.c.) in 
comaprison to low molecular weight heparin, is associated with lower bleeding rates and 
better overall survival. 
b-Blockers 
  First-line therapy in the treatment of chronicstable angina. 
The therapeutic goals of b-blocker therapy are: 
 To reduce frequency of angina 
 To reduce severity of angina 
 To improve exercise capacity without significant side effects 
  It decreases the myocardial oxygendemand by decreasing HR and 
contractility which decreases the LV wallstress and thus decreases the oxygen demand. 
 
Angiotensin-Converting Enzyme Inhibitors or Angiotensin Receptor Blockers 
Recommended for patients with 
• MI,  
• LVEF less than 40%, 
• hypertension,  
• diabetes, or  
• chronic kidney disease. 
  ACE inhibitors reduce LV afterload, and also enhance coronary microcirculation by 
promotingendothelium-mediatedvasodilation whichis  helpful in preventing 
pathologicLV remodeling. They are started within 24 hours of the acute event after the 
stabilizationof the hemodynamics. 
Nitrates 
They actas a 
• Venodilator,  
• Coronary vasodilator, and  
• Modest arteriolar dilator. 
It improve exercise tolerance, time to onset of angina, and ST-segment 
depressionduring exercise testing in patients with stable angina.  
 
Calcium Channel Blockers 
Some of the commonly used CCBs : 
 Nifedipine 
 Amlodipine 
 Verapamil and  
 Diltiazem.  
The drug ,dose and features  
Nifedipine 
Dose:5–20 mg 8-hourly 
May cause markedtachycardia 
Nicardipine 
Dose:20–40 mg 8-hourly 
May cause less myocardialdepression than the other 
calcium antagonists 
Amlodipine  
Dose:2.5–10 mg daily  
Ultra long-acting 
Verapamil 
Dose:40–80 mg 8-hourly 
Commonly causesconstipation 
useful antiarrhythmic 
properties (p. 572) 
Diltiazem 
60–120 mg8-hourly 
Similar anti-arrhythmicproperties to verapami 
Statin Therapy 
  Statin therapy reduces events and all-cause mortality. Starting of statin therapy is 
recommendedregardless of prior lipid levels.  
PERCUTANEOUS CORONARY INTERVENTION (PCI) 
     Angioplasty is the technique in which the narrowed or thr obstructed arteries are 
mechanically widened. 
     Angioplasty has also been called percutaneous transluminal coronary 
angioplasty:however, the preferred term at present is percutaneous coronary intervention. 
    In balloon angioplasty a balloon catheter is passed overa guide wire to the locations of 
the narrowed blood vessel .The balloon is then inflated to75 to 500 times the normal BP. 
The balloon crushes the fatty deposits in the vessels and thus opensup the blood vessel. 
Stents 
     A stent may be placed during a PCI procedure. It is a metal mesh tube which holds 
open the coronary artery. During a balloon angioplasty, the stent is expanded when the 
balloon expands, however, the balloon is collapsed andwithdrawn, whereas the stent 
remains in the artery permanently. The artery starts to heal around the stent. 
  There are many types of stents available depending upon the 
material,size,composition, and whether or not they are drug eluting.The drug-eluting 
stents are mostly used these days.  
Drug-eluting stents 
It consist of  
1. A metallicstent 
2. A polymer coating, and 
3. An antirestenotic drug (e.g sirolimus or paclitaxel) 
This drug is mixed with a polymer and it is released over a period of time ranging 
from days to a year. 
The drug decreases the local proliferative healing response.  Patients are typically 
placed on antithrombotic therapy after PCI and stent placement, and clopidogrel for 6 to 
12 months. 
  
Indications for PCI 
 Acute STEMI 
 Non–ST-elevation acute coronary syndrome 
 Stable angina 
 Anginal equivalent with known CAD (e.g dizziness, dyspnea,arrhythmia, and 
syncope) 
Complications of PCI 
 Dissection or perforation of the blood vessel.  
 Failure of stent deployment, 
 Stent thrombosis, and  
 Stent infection. 
The use of stents helps in maintaining the dilation of the vessel byproviding scaffolding. 
Thedrug-eluting stents decreases the rate ofclosure. The patients are placed on 
antithrombotictherapy during the postprocedure time. 
  
SURGICAL TREATMENT OPTIONS 
 Conventional Coronary Artery Bypass Grafting (CABG): 
  It is a surgical procedure which improves bloodflow to the heart by 
bypassing the diseased portion of a blood vessel. The surgery is done by opening the 
patient’s chest with an incisionover the sternum and dividing it to expose the heart. The 
vessel used tobypass the disease artery is taken from the patient. Internal mammary 
arteries are used but originally, the saphenous vein was used.The other arteries that may 
be used are the radial artery or the gastroepiploic artery. 
Minimally Invasive Coronary Artery Bypass (MIDCAB) 
 It is a procedure which is done through asmaller incision over the patient’s heart. 
It excludes the use of the heart-lung machine bacause this procedure has a much smaller 
incision.There is less pain and a rapid recovery. This technique is indicated as only for 
certain coronary vessels—the left anterior descending artery and the right coronaryartery. 
Indications for surgery 
 Angina—if a patient continues to have angina despite medical treatment , 
 specific vessel disease which has a high risk of MI or death 
 Extensive disease(patients with extensive CAD, including left main or 
multiplearteries) and  
 patients with poor LVEF 
 After MI—patients who have had an MI may undergo CABG if the 
vesselscannot be opened by angioplasty or by stent placement 
Choice of appropriate intervention for CAD depends on 
a. The extent of disease, 
b. Age 
c. Comorbidities 
d. Patient’s preference, and 
e. Evidence for potential benefit. 
SURGICAL COMPLICATIONS 
 Bleeding  
 Infection. 
 Postpump syndrome which is a complication related to the use of the bypass 
machine 
The postpump syndrome is characterized 
i. Leukocytosis, 
ii. Systemic inflammation, and 
iii. Multiorgan dysfunction 
These complications are thought to be triggered by lung 
perfusion,surgicaltrauma,and blood contact with artificial bypass circuitry. 
 Patient centred applications of cardiac imaging in coronary artery disease: 
 In CAD patients, the basis for the diagnostic application of imaging testsshould be 
viewed on the basis of pretestprobability of disease and the specific characteristics of 
imagingTests. 
In symptomatic patientspretest probability of CAD differs based upon the : 
 Typeof symptom which may be typical angina atypical angina or noncardiac 
chest pain 
 Age 
 Gender 
 Coronary risk factors. 
 The results of the initial test will inform the posttest likelihood ofCoronary Artery 
Disease. Regardless of the sequencea test willprovide sufficient information to confirm or 
exclude the diagnosis of Coronary Artery Disease and such information will allow the 
accurate risk stratifiιtionto guide management decisions. 
Stress Echocardiography  
The hallmark of myocardialischemia during a “stress echocardiography”are 
 Developmentof new regional wall motion abnormalities  
 Reduced systolic wall thickening.  
  The Stressechocardiography can also be performed in conjunctionwith 
exercise or dobutamine stress. Stress echocardiographyis best at identifying the inducible 
wall motionabnormalities in a previously normally contracting segments.  
The advantages of stress echocardiography include: 
 Its relativelygood diagnostic accuracy 
 Widespread availability 
 Nouse of ionizing radiation 
 relatively low cost. 
The limitations of stress echocardiography are:  
 Thetechnical challenges which is associated with image acquisitionat the of the 
peak exercise because of cardiac ecursion and exertional hyperpnoea  
 The rapid recovery of the wall motion abnormalities can be seen with mild 
ischemia(especially with single-vessel disease which limits the sensitivity)  
 Difficultyin detecting the residual ischemiawithin an infarcted territory because 
of the abnormality of the resting wallmotion 
 Highlyoperator dependent for the acquisition of echocardiographicdata and the 
analysis of images 
 The fact that only in 85% of patients there is good -quality complete images 
viewing all the segments of myocardium 
 Newer techniques that improve the image quality are: 
 Second harmonic imaging and 
 The use ofintravenous contrast agents 
 The effects of these new techniques on diagnostic accuracy is not yet well 
documented. Anegative stress echocardiogram is associated with a good prgnosis 
and it allows identification of patients who are at low risk. 
Stress Radionudide Imaging 
SPECT myocardial perfusion imaging : 
It isthe most common stress imaging tests for the evaluation of CAD. 
The ischemia is inicated by the presence of a reversible myocardial perfusion defect and a 
prior myocardial infarction is reflected by a fixed perfusiondefect . 
PET has advantages over SPECT. 
PET is not widely available and also it is more expensive. 
The Nuclear perfusion imaging is another approach for: 
 diagnosis of the obstructive CAD 
 quantifying the magnitude of inducible myocardialischemia 
 for the assessment of the extent of tissue viaability 
 to guide the therapeuticmanagement (i.e.for selecting patients for 
revascularization) . 
 The risks of myocardial infarction and death increase linearly with the increase in 
magnitude ofperfusion abnormalities which reflects the extent and severity of CAD. 
The limitation of this approachis 
 It uncovers only the coronary territories which is supplied by the mostsevere 
stenoses.  
 Therelative insensitivity to delineate the extent of obstructive angiographic CAD. 
 This limitation is mitigated by the use of quantitative myocardial bloodflow and 
coronary flow reserve with PET. 
 
  
HYBRID CT AND NUCLEAR PERFUSION IMAGING 
The CT coronary angiography(CAC )quantitatively measures the anatomic extent 
of atherosclerosis. 
In patients without known CAD,it provides an opportunityfor risk assessment 
using nuclear imaging alone. 
Cardiac CT 
      The improved tempora1 and spatia1 reso1utionof modern multidetector CT scanners 
is a non invasive approach to delineate the severity and the extent of coronary 
atherosclerosis.  
  It is highly sensitive approach and very effective means for excluding the 
presence of CAD. 
  The specificity decreases in the setting of high coronary calciumscores 
because theartifact of calcium makes it difficult to eva1uate the vesse11umen 
accurate1y.A normal scan result can effective1y exclude the obstructive CAD and thus 
abolishesthe need for furtherinvestigation. 
CMR Imaging 
The two approaches used with CMR are : assessment of regional 
myocardia1perfusion or the wall motion at rest the assessment during stress. 
The stress MRI studies require the useof pharmaco1ogic agents likevasodilators or 
dobutamine. 
Myocardia1 perfusion is eva1uated by injecting a bo1us of a GBCA fo1lowed by a 
continuous data acquisition. 
The re1ative perfusion deficitsare identified as regions oflow signal intensity . 
The LGE imaging detects the bright areas of myocardial scar (white)which further 
enhances theutility of this approach for diagnosis of Coronary Artery Disease. 
The advantage of dobutamine CMR over dobutamine echocardiography is the 
better image quality and also a sharper definition of endocardial borders from blood pool. 
In patients with poor acoustic window, “Dobutamine CMR” have a better 
diagnostic accuracy than the “dobutamine echocardiography”for the detection of CAD. 
The limitation of high-dose dobutaminestress CMR is the potentia1 risk of severe 
side effects(e.g hypotension and severe ventricu1ar arrhythmias). 
It occurs rarely (-5%). These side effects are prevented by propermonitoring of 
vital signs. 
  The advantage of “stressperfusion CMR” over SPECT is higher spatial 
resolutionwhich allows detectionof subendocardial defects that would have been missed 
by SPECT. 
The measurement ofischemia derived from stress CMR studieshave a prognostic 
value. 
A normal CMR study is has a good prognosis.  
The predictors of adverse events are: 
 The presence of new wall motion abnormalities  
 Regional perfusion defects  
 The combination of perfusion defects and wall motion abnormalities 
 The presence ofLGE  
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 INTRODUCTION 
 
Coronary artery disease is major cause of mortality and morbidity all over the 
world.  
Treadmill testing and transthoracic echocardiography can have limited specificity 
and sensitivity in diagnosing CAD 
Doppler Ultrasound machines facilitates comprehensive analysis of the intima-
media thickness (IMT) in the peripheral vessels--carotid arteries . 
Thickening of the intima-media is commonly recognized as the intial stage in the 
development of atherosclerosis. 
Early detection of CAD will be instrumental in introducing effective treatment and 
may contribute to reducing mortality 
Doppler Ultrasound examination offers the potential for simultaneous intervention 
in both carotid and coronary arteries. 
 
 
 
 
  
 
MATERIALS AND METHODS 
 
STUDY POPULATION 
  This study is to be conducted among 30 CAD patients  attending the 
Department of Medicine & Department of Cardiology, Govt. Rajaji Hospital, Madurai. 
Inclusion criteria 
• Patients suspected of CAD and confirmed CAD on  angiography  
• Age 30-60 years  
Exclusion criteria 
• Subjects who were previously diagnosed with Diabetes Mellitus (DM) or genetic 
dyslipidaemia 
• HIV positive subjects 
• Subjects who smoked more than 20 cigarretes per day 
• Subjects with overt renal,thyroid or liver disease; 
• Subjects were the imaging circumstances were very poor ,with limited boundary 
visualization or where there were anatomical constraints,either a high carotid 
artery bifurcation or a short thick neck ,were more than 2 segments were not 
visualised.  
 
 
ANTICIPATED OUTCOME 
 The measurement of IMT as a factor in gauging risk may have a certain potential 
for the preliminary identification of patients with or without CAD. IMT measurement is 
highly instrumental in screening patients with suspected CAD but with no history of 
myocardial infarction. Since over 50%of acute coronary syndromes (including 
myocardial infarction with ST elevation) are not accompanied by prodromal symptoms, 
B mode quantification of carotid IMT can effectively identify patients at high 
cardiovascular risk.  
 The non-invasive, inexpensive, and reproducible features of ultrasoumd 
measurements on CIMT as a predictor of future cardiovascular events, makes it a 
valuable clinical tool. 
 Aim of this study is to investigate whether an increase in IMT is related to the 
severity of CAD ,as well as whether IMT may be instrumental in identifying patients 
with or without CAD. 
DATA COLLECTION 
• A Brief history with detailed clinical examination 
LABORATORY INVESTIGATIONS: 
• Coronary angiography  
• ultrasound quantification of IMT in carotid arteries  
 
 
 STUDY PROTOCOL 
• Study group will be recruited on the basis of confirmed CAD at angiography -
defined as lesions greater than 50% in one or more of the major coronary vessels 
and patients who were suspected of having CAD . 
• Subjects with previous myocardial infarction at least 3 months post -infarction 
before recruitment. 
• High resolution B-mode, color doppler and pulse doppler of both carotid arteries 
using an ultrasound machine 
• Patients in supine position with head tilted backwards 
• Localisation of carotid arteries by transverse scans  and rotation of probe to 
90degree to obtain and record longitudinal image of the anterior and posterior 
walls 
• Measurement of maximum IMT at the near and far walls of the common carotid 
artery ,the bifurcation ,and the internal carotid artery 
• Grade of stenosis in carotid and vertebral arteries to be assessed through increase 
in peak systolic and end diastolic velocities to establish the frequency of 
concomitant CAD  and severe carotid and vertebral atherosclerosis 
• Coronary angiography in catheterisation laboratory through femoral artery access 
and lesions with more than 50% within main branches of coronary arteries were to 
be considered 
 
DESIGN OF STUDY 
Prospective analytical study 
PERIOD OF STUDY 
May 2017 TO August 2017 
COLLABORATING DEPARTMENTS: 
 Department of Medicine, Department Cardiology, Radiology 
ETHICAL CLEARANCE: Applied for 
CONSENT: Individual written and informed consent. 
ANALYSIS: Statistical analysis 
CONFLICT OF INTEREST: Nil 
FINANCIAL SUPPORT: Nil 
Method of study  
 This study was conducted in Govt. Rajaji Hospital, Madurai which is affiliated to 
Madurai Medical College.The study subjects were selected from the Patients with 
coronary artery disease or suspected of coronary artery disease attending the Department 
of Medicine & Department of Cardiology, Govt. Rajaji Hospital, Madurai. 
 All the patients had undergone coronary angiographies and ultrasound 
quantification of IMT in the carotid arteriesHigh resolution B mode ultrasonography of 
both carotid arteries were performed. 
The patients were examined in the supine position with headtilted backwards. 
After localisation of the carotid arteries, the probe was rotated 90˚ to obtain  a 
longitudinal image of the anterior and the posteriorwalls. 
The maximum IMT was measured at near and farwalls of the common carotid 
artery 2cm proximal to the bifurcation. All the measurements were taken in diastole, 
measured in phase when the lumen diameter ia at its smallest and IMT at its largest. 
All scans were obtained by the same experienced sonographer,who had no prior 
knowledge of the patient’s clinical and angiographic characteristics. The results were 
subjected for statistical analysis. Coronary angiography was performed in the 
catheterisationlaboratory the high sensitivity C-reactive protein was measured for all the 
patients. 
Three groups of patients were considered in the analysis: 
Patientspatients with one, two, and three vessel CAD. The p value was calculated 
to visualise the discriminating power ofIMT. 
Patients with three vessel CAD had significantlyhigher IMT than did patients with 
single and two vessel CAD 
Patients with moreadvanced CAD had a higher prevalence of intima-
mediacomplex thicknesses. 
To find how IMTbehaves as a predictor of CAD severity in the presence 
ofother important risk factor we included age,sex, hsCRP. 
  After a stepwise selection procedure we found 3 independent predictors of 
CAD in the final discriminationfunction: age (p < 0.001), IMT (p <0.001), 
hsCRP(p<0.002). 
  We found that the number of critically stenosed carotidincreased with 
advancing CAD. 
STUDY PROTOCOL 
• Study group will be recruited on the basis of confirmed CAD at angiography -
defined as lesions greater than 50% in one or more of the major coronary vessels 
and patients who were suspected of having CAD . 
• Subjects with previous myocardial infarction at least 3 months post -infarction 
before recruitment. 
• High resolution B-mode,color doppler and pulse doppler of both carotid arteries 
using an ultrasound machine 
• Patients in supine position with head tilted backwards 
• Localisation of carotid arteries by transverse scans  and rotation of probe to 
90degree to obtain and record longitudinal image of the anterior and posterior 
walls  
• Measurement of maximum IMT at the near and far walls of the common carotid 
artery ,the bifurcation ,and the internal carotid artery 
• Grade of stenosis in carotid and vertebral arteries to be assessed through increase 
in peak systolic and end diastolic velocities to establish the frequency of 
concomitant CAD  and severe carotid and vertebral atherosclerosis 
• Coronary angiography in catheterisation laboratory through femoral artery access 
and lesions with more than 50% within main branches of coronary arteries were to 
be considered 
 
 
 
 
 
 
  
 
 
 
 
  
RESULTS AND INTERPRETATIONS 
 
 
Age (in yrs) 
N 30 
Mean 56.5 
SD 8.2 
Minimum 42 
Maximum 69 
 
 
Age group (in yrs) n (%) 
<=45 4 (13.3) 
46 – 55 11 (36.7) 
56 – 65 9 (30.0) 
>=66 6 (20.0) 
Total 30 (100.0) 
 
The total number of patients were 30. the minimum age being 42 years and the 
maximum age 69 years. The mean for the 30 patients was 56.5. 
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Sex n (%) 
Male 21 (70.0) 
Female 9 (30.0) 
Total 30 (100.0) 
 
There were 21 male patients and 9 female patients. 
 
  
 
No. of Vessels Involved n (%) 
One 15 (50.0) 
Two 12 (40.0) 
Three 3 (10.0) 
Total 30 (100.0) 
 
By  angiography ,15 patients had single vessel involvement. 12 patients had double 
vessel involvement and 3 patients had three vessel involvement 
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50%
40%
10%No. of Vessels Involved
One Two Three
 No. of Vessels Involved 
 One (n=15) Two (n=12) Three (n=3) 
 Median (IQR) Median (IQR) Median (IQR) 
IMT 0.8 (0.5, 1.0) 1.8 (1.3, 1.9) 2.0 (1.8, 2.0) 
p-value <0.001 (Significant) 
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 No. of Vessels Involved 
 One (n=15) Two (n=12) Three (n=3) 
 Median (IQR) Median (IQR) Median (IQR) 
HS-CRP 2.9 (2.5, 3.0) 4.1 (3.0, 5.4) 4.5 (3.8, 5.0) 
p-value 0.002 (Significant) 
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RESULTS  
In the study population 13.3% were below 45 years, 36.7% between 46-55 years, 
30 % were between 56-65 years and 20% were 66 years and above.70% of the patients 
were male and only 30 % were female. 
On coronary angiography, One vessel CAD was diagnosed in 15(50%), two vessel 
CAD in 12 (40.0%), and three vesselCAD in 3 (10%) patients. 
A significant, nearly linear correlationbetween IMT and advancing CAD (p , 
0.001) was found. 
 
 
  
DISCUSSION 
 
The study group consisted of patients admitted to thedepartment with suspected 
CAD. 
B mode ultrasonography of the carotid arteries, offers the potential for effective 
evaluation ofearly atherosclerotic changes, such as the thickening of theintima-media 
complex and non-significant carotid plaques,and brings into focus the possibility of 
monitoring atheroscleroticprogress inperipheral arteries. It is found that the thickness of 
the intima-mediacomplex increases with age, sex,CAD and hsCRP. 
The present study showed that the carotid artery IMT was higher inpatients with 
angiographically confirmed CAD with tripple vessel disease than inpatients with single 
or double vessel disease. Thickening of the median aggregate intima-media complex to 
just over 0.8 mmmay prove to be predictive of single vessel disease. The median value 
hsCRP of 2.9 is indicative of the underlying chronic inflammation for the clinical course 
of CAD in patients with single vessel disease. 
 
 
  
 
 
SUMMARY OF PRIOR PUBLICATION 
 
Carotid intima -media thickness -a surrogate marker for coronary artery disease in 
the South African Black Population 
  Zaiboonnissa Holand. Faculty of health sciences, university of               
Witwatersrand, Johannesburg 
Conclusion 
The use of B-mode ultrasound to measure CIMT correlates with the extent of the 
coronary vessel involvement in CAD.CIMT could play a pivotal role in providing 
solutions ,to prevent this population with a low prevalence of CAD,from gradually 
succumbing to the hazards of upward social and economic mobility . 
Relationship between carotid intima-media thickness,atherosclerosis risk factors 
and angiography findings in patients with coronary artery disease 
Kabłak-Ziembicka A, Przewłocki T, Kostkiewicz M, Pieniazek P, Mura A, Podolec P, 
Tracz W. 
Conclusions 
 Alterations within carotid arteriesintia-media thickening and plagues were 
identified in 91.3% patients. We observed statistically significant correlation between 
IMT and advancing coronary artery disease. High-grade stenosis of carotid arteries was 
observed in 8.7% patients with coronary artery disease, furthermore in 13.7% patients 
with advanced coronary artery disease. IMT increases with age. Hypertension, 
hyperlipidemia and non-insulin-dependent diabetes mellitus are related to a greater IMT, 
whereas other risk factors didn't reveal that correlation. 
Relationships between brachial artery flow mediated dilation and carotid artery 
intima-media thickness in patients with suspected coronary artery disease. 
Furumoto T1, Fujii S, Saito N, Mikami T, Kitabatake A.Department of Cardiovascular Medicine, 
Hokkaido University Graduate School of Medicine, Sapporo, Japan 
Conclusion: FMD was reduced at early stages of CAD while IMT was increased in 
advanced CAD, and (2) inflammation and thrombosis may play a role in the early stages 
of the atherosclerotic process. 
 
 
 
 
 
 
 
 
 
SUMMARY 
Coronary artery disease is major cause of mortality and morbidity all over the 
world. There has been an alarming increase over the past two decades in coronary artery 
disease  in India.Since treadmill testing and transthoracic echocardiography can have 
limited specificity and sensitivity in diagnosing CAD ,other methods are required.This 
applies especially to patients with atypical angina or typical angina accompanied by a 
negative treadmill test and echocardiography ,at the same time reflecting an overall need 
for an introduction of new complementary diagnostic instruments. The development of 
Doppler Ultrasound machines,advanced operating software, and high resolution 
transducers facilitates comprehensive analysis of the intima-media thickness (IMT) in the 
peripheral vessels--carotid arteries. Thickening of the intima-media is commonly 
recognized as theinitial stage in the development of atherosclerosis. 
Myocardial infarction or other acute coronary syndromes are the first symptom of 
CAD in more than 50%of all patients with cardiovascular disease. Thus,early detection of 
CAD may well prove to be instrumental in introducing effective treatment and may 
contribute to reducing mortality,for example ,through plaque stabilisation and more 
aggressive control of atherosclerotic risk factors. 
The impact of hypertension ,diabetes mellitus, hyperlipidaemia,cigarrete 
smoking,age and sex on IMT has already been well established .However the association 
between IMT and atherosclorosis of the coronary arteries requires further investigations. 
Furthermore,concomitant severe carotid and atherosclerosis may increase the risk 
of periprocedural stroke in patients undergoing coronary artery bypass grafting or 
percutaneous procedures for CAD . In these patients,Doppler Ultrasound examination 
offers the potential for simultaneous intervention in both carotid and coronary arteries. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CONCLUSION 
 
From this study we came to the conclusion that IMT increases with the advancing 
CAD . 
The HsCRP value also increases with the increase in the severity of the disease. 
There is a positive correlation between the age and the Intima- media thickness. 
 
 
 
 
 
 
 
 
 
  
LIMITATIONS OF THE STUDY 
 
1. Smaller study population 
2. Shorter duration of fol;ow up of cases 
3. Other biochemical parameters were not included 
 
Further recommendations 
1. A longer duration of study in larger population should be considered in the future 
2. Treatment details such as intake of other drugs and other risk factors should be 
evaluated in the patients which has a role in altering the process of atherosclerosis 
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PROFORMA 
Name :      
Age/Sex 
Occupation: 
Smoker/non smoker: 
Presenting complaints: 
Known case of coronary artery disease or h/o chest pain 
 
Past history: 
H/o Systemic hypertension , Diabetes Mellitus , Chronic liver disease, coronary artery 
disease, chronic kidney disease, myocardial infarction, HIV 
Clinical examination: 
General examination: 
Consciousness, Pallor, jaundice, Clubbing, Lymphadenopathy,  
Vitals: PR, BP, RR, SpO2, Temperature,Height ,weight 
Systemic examination:  
CVS: 
 RS:  
Abdomen : 
 CNS: 
LABORATORY INVESTIGATIONS: 
1.ECG 
2.Treadmill test 
3.Echocardiography 
4.Coronary angiography 
5.Doppler ultrasonography of both carotid arteries 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
MASTER CHART  
 
NAME AGE SEX DIAGNOSIS 
NO.OF VESSELES 
INVOLVED 
IMT 
HS-
CRP 
Ravi 54 M CAD 1 1 2 
Ponram 65 M CAD 2 1.2 2.9 
Jamuna 66 F CAD 2 1.2 2.8 
Selvi 69 F CAD 3 1.8 3.8 
Thangaraj 56 M CAD 1 0.8 2.9 
Santhosh 52 M CAD 1 0.5 3 
Rajkumar 62 M CAD 2 1.03 5.4 
Kiran 43 F CAD 1 1 3 
Ashadevi 50 F CAD 2 1.7 3.05 
Yogesh 47 M CAD 1 0.9 2.9 
Balamurgan 42 M CAD 1 0.6 3.2 
Pavithra 60 F CAD 2 1.8 3.3 
Thulasi 55 F CAD 1 1 2.8 
Thambi 54 M CAD 2 1.9 3.04 
Arun 44 M CAD 1 1 3.01 
Akash 67 M CAD 3 2.02 4.5 
Naren 50   M CAD 1 0.5 2.3 
Meenakshi 67 F CAD 2 1.8 3.09 
Babulal 60 M CAD 2 2 5.3 
Mahendran 64 M CAD 2 2.5 5.02 
Vinothan 45 M CAD 1 0.6 3.2 
Nagaraj 49 M CAD 1 0.7 2.5 
Vallidevi 67 F CAD 3 2.05 5.03 
Lakshmi 54 F CAD 1 0.5 2.03 
Nehru 53 M CAD 1 0.54 3.09 
Gandhi 62 M CAD 2 1.7 5.5 
Ramesh 63 M CAD 2 1.8 5.9 
Ranjith 60 M CAD 1 1.01 3.2 
Marimuthu 66 M CAD 2 2.2 6 
Guruvammal 49 M CAD 1 0.9 2.5 
 
 
  
  
 
 
 

 
  
 
 
 
 
 
